Thinking of joining a study?

Register your interest

Become a volunteer?

Clinical trials

4405 results

Sort By:

Genistein on Post-myocardial Infarction Patient With Elevated hsCRP

Study ID: NCT06689566
Start Date: 2024-12
End Date: 2027-12
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

73

Intervention / Treatment

genistein

Sponsor

National Taiwan University Hospital

Source: clinicaltrials.gov

Share:
Add to list

Post-Intensive Care Transitional Care, Rehabilitation, and Family-Support

Study ID: NCT06501365
Start Date: 2025-01-01
End Date: 2029-12-31
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

320

Intervention / Treatment

Post Intensive Care Transitions Rehabilitation and Family Support (PIC-TRFS)

Enhanced Usual Care Control

Sponsor

University of Pittsburgh

Source: clinicaltrials.gov

Share:
Add to list

Art Therapy in Progressive Supranuclear Palsy

Study ID: NCT06588673
Start Date: 2025-01
End Date: 2026-09-02
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

10

Intervention / Treatment

Art Thrapy

Sponsor

Vanderbilt University Medical Center

Source: clinicaltrials.gov

Share:
Add to list

Study on the Contribution of the Genetic Tumor Profile Obtained by Circulating Tumor DNA Analysis in the Multidisciplinary Molecular Biology Meeting of Eastern PACA

Study ID: NCT06606366
Start Date: 2025-02
End Date: 2027-05
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

216

Intervention / Treatment

Blood sample taken for the liquid biopsy

Sponsor

Antoine Lacassagne Center

Source: clinicaltrials.gov

Share:
Add to list

Post Market Registry for GORE® TAG® Thoracic Branch Endoprosthesis

Study ID: NCT06507865
Start Date: 2025-01
End Date: 2031-04
Study Type

Observational

Study Phase

Not Applicable

No. of Participants

200

Intervention / Treatment

GORE® TAG® Thoracic Branch Endoprosthesis

Sponsor

W.L.Gore & Associates

Source: clinicaltrials.gov

Share:
Add to list

Study Investigating the Safety of CD19 CAR-T Cells in Relapsed/Refractory AML Expressing CD19

Study ID: NCT06649227
Start Date: 2025-01-01
End Date: 2029-01-01
Study Type

Interventional

Study Phase

Phase1

No. of Participants

5

Intervention / Treatment

CAR-T cell therapy

Sponsor

University Hospital, Lille

Source: clinicaltrials.gov

Share:
Add to list

Pilot Study of Health System/Community Partnership for Enhanced Outreach to Prevent Suicide Attempts

Study ID: NCT05825820
Start Date: 2026-01
End Date: 2026-08
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

20

Intervention / Treatment

Enhanced Outreach Intervention (EOI) plus Care as Usual

Sponsor

Massachusetts General Hospital

Source: clinicaltrials.gov

Share:
Add to list

Deucravacitinib in PG

Study ID: NCT05821374
Start Date: 2025-03
End Date: 2026-01
Study Type

Interventional

Study Phase

Early_phase1

No. of Participants

10

Intervention / Treatment

Deucravacitinib

Sponsor

Dartmouth-Hitchcock Medical Center

Source: clinicaltrials.gov

Share:
Add to list

Value of Speckle Tracking Echocardiography Inflammatory Bowel Disease Patients

Study ID: NCT06695065
Start Date: 2024-12-01
End Date: 2027-12-01
Study Type

Observational

Study Phase

Not Applicable

No. of Participants

100

Intervention / Treatment
Sponsor

Assiut University

Source: clinicaltrials.gov

Share:
Add to list

Strength Training and Resveratrol

Study ID: NCT06585865
Start Date: 2025-02
End Date: 2026-08
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

36

Intervention / Treatment

Resistance training

Resveratrol 500 mg oral once daily.

Placebo

Sponsor

Texas Tech University

Source: clinicaltrials.gov

Share:
Add to list